Research Article Synergistic Effect of Zuo Jin Wan on ... - BioMedSearch

Hindawi Publishing Corporation Evidence-Based Complementary and Alternative Medicine Volume 2014, Article ID 724764, 10 pages http://dx.doi.org/10.1155/2014/724764

Research Article Synergistic Effect of Zuo Jin Wan on DDP-Induced Apoptosis in Human Gastric Cancer SGC-7901/DDP Cells Qing-Feng Tang,1 Qing Ji,1 Yan-Yan Qiu,2 Ai-Li Cao,3 Yang-Feng Chi,2 Bo Liang,2 Wen Peng,3 and Pei-Hao Yin2 1

Department of Clinical Laboratories & Experimental Center, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200062, China 2 Department of General Surgery, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200062, China 3 Department of Nephrology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200062, China Correspondence should be addressed to Wen Peng; [email protected] and Pei-Hao Yin; [email protected] Received 25 November 2013; Accepted 28 January 2014; Published 3 March 2014 Academic Editor: Cheorl-Ho Kim Copyright © 2014 Qing-Feng Tang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. A traditional Chinese medicine (TCM) formula, Zuo Jin Wan (ZJW), has been found as an anticancer drug in human cancer. In this study, we investigated the synergistic effect of ZJW extracts on DDP-induced apoptosis in human gastric cancer SGC-7901/DDP cells. Our results demonstrated that ZJW extracts could increase the sensitivity of SGC-7901/DDP cells to DDP by increasing the concentration of DDP in cytoplasm and enhance the proapoptosis of DDP by upregulating the JNK and Bax expression, downregulating the Bcl-2 expression, increasing the accumulation of Cytochrome C in cytoplasm, and promoting the activities of caspase-3 and caspase-9. In vivo, ZJW extracts enhanced the inhibiting effect of DDP on tumor growth in SGC-7901/DDP xenograft model and upregulated the expression of p-JNK and Bax but downregulated the Bcl-2 expression in xenograft tumors. In conclusion, in vitro and in vivo, ZJW extracts could enhance the proapoptotic effect of DDP by promoting the activation of JNK and the expression of Bcl-2, inhibiting the Bax expression, followed by increasing the release of Cytochrome C from mitochondria to cytoplasm, and finally activating the caspase cade reaction. Our results implied that ZJW might serve as a synergistic drug with chemotherapeutic drugs DDP in the treatment of gastric cancer.

1. Introduction Presently, chemotherapeutic drug resistance has been recognized as one of the primary problems in the therapy of cancer [1–3]. Because of its complicated mechanism, effective methods for solving this problem still have not been found. As far as we know, Traditional Chinese Medicines (TCMs) have been used as western medicines or health supplements in the past thousands of years. In clinical practice, lots of Traditional Chinese prescriptions and formulate, which are based on TCM principles, have been identified as effective anticancer drugs in cancer patients, such as gastric cancer [4], breast carcinoma [5], and colorectal cancer [6]. Compared with chemotherapeutic drugs, Traditional Chinese Medicines

could also control cancer progression effectively [7], prolong survival periods [8], and improve life quality [9]. Zuo Jin Wan (ZJW) is a typical TCM formula, which consists of the Rhizoma Coptidis and Fructus Evodiae in the ratio of 6 : 1 (w/w). Fructus Evodiae could induce apoptosis in cancer cells, such as human hepatocellular carcinoma SMMC-7721 cells [10], human melanoma A375-S2 cells [11], and human colorectal carcinoma COLO-205 cells [12]. Since ZJW herbal formula has anticancer effect, its underlying mechanisms need further investigation. In the present study, we elucidated the effect and the molecular mechanism of Chinese herbs formula ZJW in human gastric cancer SGC7901/DDP cells in vitro and in vivo and provided possible target for the therapy of gastric cancer.

2

2. Materials and Methods 2.1. Preparation of the ZJW Extracts. ZJW was formulated by Rhizoma Coptidis and Evodiae, in a ratio of 6 : 1. The above two herbs were purchased from Putuo Hospital, Shanghai University of Traditional Chinese Medicine. ZJW was extracted twice by refluxing in ethanol (1 : 8, v/v), each time for 1 hour. Put together the extracted mixtures were filtrated, concentrated, and dried in vacuum at 60∘ C. The yield of dried powder was about 24.4%, and the extract was stored at 4∘ C. Preparation of the ZJW extracts was standardized and quality controlled according to the guidelines from Chinese State Food and Drug Administration (SFDA). For all the experiment, the above ZJW extract powders were dissolved in RPMI 1640 medium by vortex, ultrasonic, and bath, followed by filtration, and formulated into a solution of desired concentration. 2.2. Cell Culture. SGC-7901/DDP cell lines were obtained from Keygen Biotech Co., Ltd. (Nanjing, China). The cells were grown in RPMI 1640 medium supplemented with 10% (v/v) fetal calf serum (FCS, Gibico, USA), 100 𝜇g/mL streptomycin, and 100 units/mL penicillin, in 5% CO2 humidified atmosphere, at 37∘ C. SGC-7901/DDP cells were routinely maintained in the above RPMI 1640 medium containing 10 𝜇g/mL Diamminedichloroplatinum (DDP, Qilu Pharmaceutical Co., Ltd., Shandong, China). 2.3. Analysis of Cells Viability. Cell Counting Kit-8 (CCK8) was chosen to determine cells proliferation. Briefly, SGC-7901/DDP cells were seeded in 96-well plates at 1 × 104 cells/well; when the cells reached 60% confluence, the medium was removed and replaced with fresh medium containing varying concentrations of ZJW and incubated for 48 hours. After incubation with culture medium containing CCK-8 reagent for 4 hours, the absorbance was detected at 450 nm using a microplate reader (Biorad, USA). All the experiments were repeated three times. 2.4. ICP-MS Analysis. SGC-7901/DDP cells were washed three times with PBS and digested, and the collected cells were washed. 500 𝜇L ddH2 O was added and the cells were broken by freezing and thawing with liquid nitrogen repeatedly followed by sonication. They were centrifuged for 10 min at 14000 rpm/min, the supernatant was collected, dried under vacuum for 24 h, and dissolved in PBS. The dissolved samples were digested by 2 mL nitric acid followed by 1 mL perchloric acid, cooled down, set to constant volume of 10 mL, and ultrafiltrated. The ultrafiltrated samples (10 mL) were diluted using a Gilson ASPEC XLi programme to deliver 1.8 mL of iridium internal standard (0.005 mg/mL, in 1% nitric acid) and mixed thoroughly. Intracellular accumulation of DDP in each sample was determined by ultrasensitive multicollector inductively coupled with mass spectrometry (ICP-MS) as previously described [13]. 2.5. Flow Cytometry Analysis. SGC-7901/DDP cells were plated in 6-well plates at 4 × 105 cells/well and starved

Evidence-Based Complementary and Alternative Medicine overnight in RPMI 1640 medium with 0.5% serum. Being treated with ZJW of different concentration for 48 hours, the cells were collected, washed with cold PBS twice, and resuspended gently in 400 𝜇L binding buffer. 5 𝜇L Annexin VFITC was added to the above cells solution, gently vortexed, and incubated for 10 min at 4∘ C avoiding the light. 10 𝜇L propidium iodide (PI) was added and cultured for another 5 minutes. Flow cytometry was then conducted using FACSCalibur Flow Cytometry (BD Biosciences, USA), and the results were analyzed with CellQuest software. 2.6. Western Blotting. Cytoplasmic proteins from SGC7901/DDP cells were prepared using a ProteoJET cytoplasmic kit (Fermentas, USA). All proteins were loaded onto SDS-PAGE gels for electrophoresis, transferred onto PVDF membranes, and blocked in 5% BSA prior to incubation with primary and secondary antibody. The resulting immunocomplexes were visualized by enhanced chemiluminescence. Each lane was photographed and quantified. All the experiments were repeated three times. 2.7. Analysis of Caspase-3 and Caspase-9 Protease Activity. SGC-7901/DDP cells were seeded in a 96-well plate and starved overnight in RPMI 1640 medium with 0.5% serum. Being treated with ZJW of different concentration for 48 hours, 100 𝜇L of Caspase-Glo 3 or Caspase-Glo 9 reagent (Promega, USA) was added to each sample and incubated at room temperature for another 2 hours. The luciferase activity was measured using a TD 20/20 luminometer (Promega, USA). Each sample was measured in triplicate. 2.8. Tumor Mouse Model. SGC-7901/DDP cells were harvested in serum-free PBS and 100 𝜇L single-cell suspensions (2 × 107 cells/mL) were injected into the subcutaneous area of female BALB/c nude mice (4–6 weeks old, SLAC Laboratory Lab, Shanghai, China). When the tumors reached an average size of 100 mm3 , the mice were randomized into 5 groups (𝑛 = 10). Mice in group 1 were administered with normal saline daily, mice in group 2 were administered with 10 𝜇g/mL DDP, mice in groups 3, 4, and 5 proceeded intragastric administration of ZJW extracts at doses of different concentration (dose calculation is referred in our previous experiment [14]), plus 10 𝜇g/mL DDP, respectively. The length and width of tumors were recorded every 7 days. After 35 days, animals were sacrificed by cervical dislocation in deep anesthesia of CO2 and primary tumors were surgically removed and weighed. Tumor sizes were evaluated using the formula: length × width2 × 0.52. The primary tumors were analyzed by hematoxylin-eosin (HE) staining, and p-JNK, Bax, and Bcl-2 proteins were detected by immunohistochemistry. All experimental protocols were reviewed and approved by the Committee on Animal Experimentation. 2.9. Statistical Analysis. The data processing was performed with SPSS18 Software. All the data results are expressed as mean ± standard deviation (𝑋 ± 𝑆). The mean values of two groups were compared by Student’s 𝑡 test. A value of 𝑃 < 0.05 was statistically significant.

Evidence-Based Complementary and Alternative Medicine

3 100 90

100 Cell inhibition rate (%)

Cell survival proportion (%)

120

80 60 40 20

80 70 60 50 40 30 20 10

0

0 0

12.5

25

37.5

50

62.5

75

87.5

100 112.5

0

10

Concentration of ZJW (𝜇g/mL)

20

30

40

50

60

70

80

Concentration of DDP (𝜇g/mL)

SGC-7901/DDP SGC-7901/DDP + ZJW (50 𝜇g/mL) (a)

(b)

8

IC50 0f DDP (𝜇g/mL)

7 6 5

∗

4 ∗∗

3 2 1 0 0

12.5

25

50

Concentration of ZJW (𝜇g/mL) (c)

Figure 1: Effect of ZJW extracts on the sensitivity to chemotherapeutic drug in SGC-7901/DDP cells. (a) Cells were treated with ZJW extracts of gradual concentrations for 48 hours, and cell survival proportion was analyzed by CCK-8 assay. (b) Effect of DDP on the proliferation of SGC-7901/DDP cells treated with or without 50 𝜇g/mL ZJW extracts for 48 hours was performed by CCK-8 assay. (c) CCK-8 assay was used to detect IC50 of DDP in SGC-7901/DDP cells treated with ZJW extracts of 12.5 𝜇g/mL, 25 𝜇g/mL, and 50 𝜇g/mL for 48 h. ∗ 𝑃 < 0.05 or ∗∗ 𝑃 < 0.01, versus control groups treated without ZJW extracts.

3. Results 3.1. Effect of ZJW Extracts on the Sensitivity to DDP in SGC7901/DDP Cells. Our previous research has made quantitative analysis of various active compounds in the ZJW extracts [14]. Simply, quantitative results of jatrorrhizine, palmatine, and berberine in Rhizoma Coptidis were 3.8%, 6.4%, and 57.1%, respectively; evodiamine and rutaecarpine in Evodia were 2.29% and 3.18%. For avoiding the possibility that inhibition of cell proliferation is due to cytotoxicity, the cytotoxic concentration of ZJW extracts on SGC-7901/DDP cells was investigated first by CCK-8 assay. At present, IC10 was a permitted standardization of the noncytotoxic dose, and our study showed that the IC10 of ZJW extracts on SGC-7901/DDP cells was about 50 𝜇g/mL (Figure 1(a)). Next, to determine the best effect of ZJW on the sensitivity to DDP in SGC7901/DDP cells, IC50 of DDP on SGC-7901/DDP cells treated

or no treated with 50 𝜇g/mL ZJW extracts was detected. The results showed that IC50 of DDP on lonely SGC-7901/DDP cells was 6.73 ± 0.72 𝜇g/mL, but with addition of 50 𝜇g/mL ZJW extracts, IC50 of DDP decreased from 6.73 ± 0.72 𝜇g/mL to 2.83 ± 0.41 𝜇g/mL (Figure 1(b)). Finally, we analyzed the effect of ZJW extracts with different concentrations on SGC7901/DDP cells, in the presence of 6.73 ± 0.72 𝜇g/mL DDP. Data showed that ZJW extracts could enhance the sensitivity of DDP on SGC-7901/DDP cells in a dose dependent manner (Figure 1(c)). 3.2. Effect of ZJW Extracts on the Apoptosis and Cycle of SGC-7901/DDP Cells. Flow cytometry was performed to see the effect of ZJW extracts on the apoptosis and cycle of SGC-7901/DDP cells. The results showed that exposure to ZJW extracts increased DDP-induced cell apoptosis in a dose dependent manner (Figure 2(a)). However, cell cycle analysis

4


SGC-7901/DDP

102

102

101

101 100

100

100 101 102 Annexin V-FITC DDP + ZJW (12.5 𝜇g/mL)

100 101 102 Annexin V-FITC

103

DDP + ZJW (25 𝜇g/mL)

103

102

101

101

101

PI

102

100

100


103


103

102 PI

PI

103

DDP

103

PI

PI

103

100


103


103

103

(a)

600 500 400 300 200 100 0

DDP

Number

Number

SGC-7901/DDP

0

50

100 150 200 DNA content

50

100 150 200

100 150

200

600 500 400 300 200 100 0


Number

Number

DNA content

50


Number 0

0

DNA content

DDP + ZJW (12.5 𝜇g/mL) 600 500 400 300 200 100 0

600 500 400 300 200 100 0

0

50


600 500 400 300 200 100 0

0

50


(b)

Figure 2: Effect of ZJW extracts on the apoptosis and cycle of SGC-7901/DDP cells. (a), (b) Flow cytometry analysis of cell apoptosis and cycle distribution was performed on SGC-7901/DDP cells treated, respectively, with 6.73 𝜇g/mL DDP, 6.73 𝜇g/mL DDP + 12.5 𝜇g/mL ZJW, 6.73 𝜇g/mL DDP + 25 𝜇g/mL ZJW, and 6.73 𝜇g/mL DDP + 50 𝜇g/mL ZJW, with the control group treated without DDP and ZJW.


5

Intracellular concentration of DDP (ng/5 × 105 cells)

250 ∗∗

200 150 ∗ 100 50 0 0

12.5 25 Concentration of ZJW (𝜇g/mL)

50

Total DDP (10 𝜇g/mL)

Figure 3: Impact of ZJW extracts on the accumulation of DDP in SGC-7901/DDP cells. ICP-MS method was used to detect intracellular DDP accumulation in SGC-7901/DDP cells treated with ZJW extracts of 12.5 𝜇g/mL, 25 𝜇g/mL, and 50 𝜇g/mL for 48 h. ∗ 𝑃 < 0.05 or ∗∗ 𝑃 < 0.01, in contrast to control groups treated without ZJW extracts.

showed that there was little change in any phase arrest in response to treatment with ZJW extracts compared with control group (Figure 2(b)). This suggested that ZJW extracts did not change cell cycle in SGC-7901/DDP cells, and the effect of ZJW extracts was most likely obtained by enhancing the DDP-induced apoptosis. 3.3. Impact of ZJW Extracts on the Accumulation of DDP in SGC-7901/DDP Cells. Using ICP-MS for determination of the changed intracellular DDP concentration in SGC7901/DDP cells, we found that, with 6.73 𝜇g/mL DDP and different concentrations of ZJW extracts exposed to SGC7901/DDP cells for 48 hours, the intracellular accumulation of DDP increased in a dose dependent manner (Figure 3). This implied that ZJW extracts had the function of promoting translocation of DDP from extracellular to intracellular. 3.4. Effect of ZJW Extracts on the Apoptosis-Related Proteins in SGC-7901/DDP Cells. To further investigate the underlying proapoptotic mechanisms of ZJW extracts on SGC7901/DDP cells, we detected the levels of apoptosis-related proteins in SGC-7901/DDP cells, including JNK, p-JNK, Bax, Bcl-2, Cytochrome C, Caspase-9, and Caspase-3. As shown in Figures 4(a) and 4(b), with the increasing concentration of ZJW extracts, 12.5 𝜇g/mL, 25 𝜇g/mL, and 50 𝜇g/mL, the active level of p-JNK was significantly increased in SGC-7901/DDP cells, although the total JNK protein expression changed a little. In addition, the expression of Bax and Cytochrome C increased but Bcl-2 decreased in a dose dependent manner. The activities of Caspase-9 and Caspase-3 were also detected, and their activities elevated with the increasing concentration of ZJW extracts (Figure 4(c)). This suggested that the proapoptotic effect of ZJW extracts in SGC-7901/DDP cells might be dependent on the activation of JNK, followed by the promotion of Bcl-2 and inhibition of Bax, further increased release of Cytochrome C from mitochondria to cytoplasm, and finally the activation of caspase cade reaction.

3.5. Impact of ZJW Extracts on Subcutaneous Xenograft of SGC-7901/DDP in Nude Mice. To explore whether ZJW extracts enhanced the proapoptotic effect of DDP in vivo, we employed a subcutaneous xenograft model. As shown in Figure 5(a), the combination of DDP and ZJW extracts produced a significant inhibition of tumor growth compared with animals treated with DDP alone, and ZJW extracts helped DDP inhibit the mice tumor volume in a dose dependent manner. The final tumor weights also showed the synergistic effect ZJW extracts and DDP (Figure 5(b)). By HE staining of tumor tissues, we observed the morphological changes of tumor cells by inverted microscope. In the SGC-7901/DDP group, tumor cells were arranged regularly, growth of tumor cells was active, more mitosis, and less cytoplasm. In the 0.6 mg/kg DDP alone group, very small necrosis appeared, and the volume of tumor cells became smaller. In the presence of 0.6 mg/kg DDP, with the increasing concentration of ZJW extracts, the necrosis area of tumor sheet increased by degrees, cells became more and more smaller and were arranged more irregularly, the nuclei was dark stained and condensed, and rich cytoplasm and a piece of hyaline change were seen (Figure 5(c)). Additionally, we detected the expression of p-JNK, Bax, and Bcl-2 in the xenograft tumor tissues by immunohistochemistry. The pictures showed that the expression of p-JNK and Bax increased with the gradually increasing concentration of ZJW extracts. However, expression of Bcl2 was the opposite trend. This implied that ZJW extracts might enhance the proapoptotic effect of DDP and could be provided as synergistic chemotherapy drugs with DDP in the treatment of gastric cancer (Figure 6).

4. Discussions In the process of cancer chemotherapy, the most intractable problem is the appearance of drug resistance of tumor cells to chemotherapeutic agents. In clinical practice, Chinese

6

Evidence-Based Complementary and Alternative Medicine ZJW (𝜇g/mL)

Mock

12.5

DDP

25

50

GAPDH

t-JNK

p-JNK

Bax

Bcl-2

Cyto.C (a)

1.2

∗∗

1

∗∗ ∗

∗

0.8

∗∗ ∗ ∗

0.6 0.4

∗∗

0.2 0

Fold change of caspase activity

Relative protein expression

12 ∗∗

∗∗

10 8

∗

∗

Caspase-9

Caspase-3

6 4 2 0

t-JNK

p-JNK

Bax

SGC-7901/DDP DDP DDP + ZJW (12.5 𝜇g/mL)

Bcl-2

Cyto.C

DDP + ZJW (25 𝜇g/mL) DDP + ZJW (50 𝜇g/mL)

(b)

SGC-7901/DDP DDP DDP + ZJW (12.5 𝜇g/mL)

DDP + ZJW (25 𝜇g/mL) DDP + ZJW (50 𝜇g/mL)

(c)

Figure 4: Effect of ZJW extracts on the apoptosis-related proteins in SGC-7901/DDP cells. (a) Western blotting was carried out to detect the expression level of total JNK, p-JNK, Bax, Bcl-2, and Cytochrome C in SGC-7901/DDP cells treated with ZJW extracts of 12.5 𝜇g/mL, 25 𝜇g/mL, and 50 𝜇g/mL for 48 h. GAPDH was used as internal reference. (b) Quantity of the expression level of total JNK, p-JNK, Bax, Bcl-2, and Cytochrome C was performed, ∗ 𝑃 < 0.05 or ∗∗ 𝑃 < 0.01, in contrast to control groups treated with DDP alone. (c) Activities of caspase-9 and caspase-3 were detected in SGC-7901/DDP cells treated with ZJW extracts of 12.5 𝜇g/mL, 25 𝜇g/mL, and 50 𝜇g/mL for 48 h. ∗ ∗∗ 𝑃 < 0.05 or 𝑃 < 0.01, in contrast to groups treated with DDP alone.

medicine drugs have showed good synergism in chemotherapy, which have been proven in numerous studies [6, 15, 16]. Chinese medicine believes that one of the pathogenesis of gastric cancer is the disharmony of liver and gastric, so there was the strong theoretical basis on the ZJW treatment of gastric cancer from the perspective of pathogenesis. In

recent years, ZJW showed comprehensive potentiality in early prevention and treatment of cancer [10–12]. ZJW could inhibit acquired multidrug resistance of tumor originated from S180 cells and improve the quality life, body mass, white blood cell count, and immune organs index of tumor-bearing mice [17]. Modern pharmacological studies have shown that


7

1600

1.4

1400

1.2 Tumor weight (g)

Tumor volume (mm3 )

1.6

1200 1000 800 600

1 0.8

∗

0.6

∗∗

0.4

400

0.2

200

0

0 0

7

14

21

28

35 SGC-7901/DDP DDP DDP + ZJW (L-dose)

Time (days) SGC-7901/DDP DDP DDP + ZJW (L-dose)

DDP + ZJW (M-dose) DDP + ZJW (H-dose)

(a)

DDP + ZJW (M-dose) DDP + ZJW (H-dose)

(b)

DDP

SGC-7901/DDP

HE

DDP + ZJW (L-dose)

DDP + ZJW (M-dose)

DDP + ZJW (H-dose)

(c)

Figure 5: Impact of ZJW extracts on subcutaneous xenograft of SGC-7901/DDP cells in nude mice. (a) Mice were divided into five groups, group 1: normal saline; group 2: 5 mg/kg DDP; group 3: 500 mg/kg ZJW (L-dose) + 0.6 mg/kg DDP; group 4: 1000 mg/kg ZJW (M-dose) + 0.6 mg/kg DDP; group 5: 2000 mg/kg ZJW (H-dose) + 0.6 mg/kg DDP. Tumor volume was measured every seven days. (b) Tumors were surgically removed from nude mice and weighed after administration for 35 days. ∗ 𝑃 < 0.05 or ∗∗ 𝑃 < 0.01, in contrast to groups treated with DDP alone. (c) Morphological changes of tumor cells were detected by HE staining, and the photograph was observed by inverted microscope.

the compatibility of two drugs could be used to inhibit the growth and migration of tumor cells, promote apoptosis of tumor cells, and block the effect of cancer-promoting substances on potential cancer cells [18, 19]. To further investigate the effect mechanism of ZJW extracts on gastric cancer, human gastric cancer SGC-7901/ DDP cells, which have resistance to a variety of chemotherapeutic drugs, were chosen for our present study. Immediately we determined the nontoxic dose of ZJW extracts, combined

ZJW extracts with DDP to treat SGC-7901/DDP cells, and found that ZJW extracts could increase the killing effect of DDP on SGC-7901/DDP cells and elevate the apoptosis rate of SGC-7901/DDP cells. However, ZJW extracts had little effect on the cycle of SGC-7901/DDP cells. Further research demonstrated that ZJW extracts made an increasing accumulation of DDP in SGC-7901/DDP cells, which implied that ZJW extracts had the function of promoting translocation of DDP from extracellular to intracellular.

8

Evidence-Based Complementary and Alternative Medicine DDP

SGC-7901/DDP

DDP + ZJW (L-dose) DDP + ZJW (M-dose) DDP + ZJW (H-dose)

p-JNK

Bax

Bcl-2

Integrated optical density (IOD)

2500 ∗∗

2000

∗∗

∗∗ 1500 1000

∗

∗∗ ∗

∗

∗∗

500

∗∗

0 p-JNK

Bax

SGC-7901/DDP DDP + ZJW (M-dose) DDP

Bcl-2 DDP + ZJW (H-dose) DDP + ZJW (L-dose)

Figure 6: Impact of ZJW extracts on the expression level of p-JNK, Bax, and Bcl-2 in vivo. The xenograft tumor tissues in mice of all groups was subjected to immunohistochemistry analysis using antibody of p-JNK, Bax, and Bcl-2, and the pictures were magnified ×200 in microscope.

While investigating the underlying proapoptotic mechanisms of ZJW extracts on DDP-induced apoptosis in SGC7901/DDP cells, we found that the synergistic effect of ZJW extracts on proapoptosis of DDP in SGC-7901/DDP cells might be dependent on the activation of JNK, which played vital role in the development of cancer [20, 21]. Upon activation of JNK, the p-JNK blocked the Bax level and promoted the Bcl-2 level. As we have known, the ratio of Bax and Bcl-2 was responsible for a variety process of apoptosis [22–24]. Hereafter, we found that release of Cytochrome C from mitochondria to cytoplasm increased, which involved in typically mitochondrial apoptosis pathway [25, 26]. Finally, caspase-9 and caspase-3 were activated, which led to the ultimate apoptosis of cancer cells [27, 28]. According to in vitro results, we conducted subcutaneous xenograft model

to validate the possible synergistic effect of ZJW extracts on proapoptosis of DDP in vivo. In light of our in vitro data on the effect of ZJW extracts in human gastric cancer SGC-7901/DDP cells to chemotherapeutic drugs, we examined the in vivo therapeutic potential of ZJW extracts. In vivo experiments results showed that the anticancer effect of ZJW extracts on SGC-7901/DDP cells xenograft was better than that of DDP alone group. In this study, we provided evidence that combination of DDP with herbal medicine formula ZJW extracts promoted the growth inhibition effect of xenograft tumors and promoted the apoptosis of tumor cells in xenograft tumors. The immunohistochemistry results showed that the expression of p-JNK and Bax increased, but Bcl-2 decreased with the gradually increasing concentration of ZJW extracts, which

Evidence-Based Complementary and Alternative Medicine implied that ZJW extracts might enhance the proapoptotic effect of DDP and could be provided as synergistic drugs with DDP in the treatment of gastric cancer. In conclusion, noncytotoxic ZJW extracts could enhance the proapoptotic effect of DDP in human gastric cancer SGC7901/DDP cells through increasing the intracellular accumulation of DDP, which promoted the activation of JNK, followed by the promotion of Bcl-2 and inhibition of Bax, further increased release of Cytochrome C from mitochondria to cytoplasm, and finally the activation of caspase cade reaction.

9

[7]

[8]

[9]

Conflict of Interests The authors declare that there is no conflict of interests regarding the publication of this paper.

Authors’ Contribution

[10]

[11]

Qing-Feng Tang and Qing Ji contributed equally to this work.

Acknowledgments This work was supported by National Natural Science Foundation of China (81303102), Program of Shanghai Municipal Education Commission (2012JW67), Program of Shanghai Municipal Health Bureau (20114037), Shanghai Committee of Science and Technology, China (no. 114119b3100), Putuo District Committee of Science and Technology, Shanghai China (no. 201102), and Construct Program of the Key Discipline of State Administration of Traditional Chinese Medicine of People’s Republic of China.

[12]

[13]

[14]

References [1] Q. Li, H. Sui, and Z.-Z. Fan, “Signal transduction pathways and transcriptional mechanisms of ABCB1/Pgp-mediated multiple drug resistance in human cancer cells,” Journal of International Medical Research, vol. 40, no. 2, pp. 426–435, 2012. [2] H. Sui, S. Zhou, Y. Wang et al., “COX-2 contributes to Pglycoprotein-mediated multidrug resistance via phosphorylation of c-Jun at Ser63/73 in colorectal cancer,” Carcinogenesis, vol. 32, no. 5, pp. 667–675, 2011. [3] H. Sui, L.-H. Zhou, P.-H. Yin et al., “JNK signal transduction pathway regulates MDR1/ p-glycoprotein-mediated multi drug resistance in colon carcinoma cells,” World Chinese Journal of Digestology, vol. 19, no. 9, pp. 892–898, 2011. [4] A. Rasul, B. Yu, L.-F. Yang et al., “Induction of mitochondriamediated apoptosis in human gastric adenocarcinoma SGC7901 cells by kuraridin and nor-kurarinone isolated from sophora flavescens,” Asian Pacific Journal of Cancer Prevention, vol. 12, no. 10, pp. 2499–2504, 2011. [5] W.-Y. Li, S.-W. Chan, D.-J. Guo, M.-K. Chung, T.-Y. Leung, and P. H.-F. Yu, “Water extract of Rheum officinale Baill. induces apoptosis in human lung adenocarcinoma A549 and human breast cancer MCF-7 cell lines,” Journal of Ethnopharmacology, vol. 124, no. 2, pp. 251–256, 2009. [6] Q. Li, H. Sui, X. Liu et al., “Reversal effect of Jianpi Jiedu Recioe on JNK/SAPK signal transduction pathway-mediated multidrug resistance in human colon carcinoma cells,” China

[15]

[16]

[17]

[18]

[19]

[20]

Journal of Traditional Chinese Medicine and Pharmacy, vol. 27, no. 3, pp. 731–735, 2012. R. E. Carroll, R. V. Benya, D. K. Turgeon et al., “Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia,” Cancer Prevention Research, vol. 4, no. 3, pp. 354–364, 2011. N.-D. Cao, A.-G. Zhao, and J.-K. Yang, “Survival time of advanced gastric cancer patients treated with integrated traditional Chinese and Western medicine therapy,” Zhong Xi Yi Jie He Xue, vol. 8, no. 2, pp. 116–120, 2010. K. K. L. Chan, T. J. Yao, B. Jones et al., “The use of Chinese herbal medicine to improve quality of life in women undergoing chemotherapy for ovarian cancer: a double-blind placebocontrolled randomized trial with immunological monitoring,” Annals of Oncology, vol. 22, no. 10, pp. 2241–2249, 2011. X.-N. Wang, X. Han, L.-N. Xu et al., “Enhancement of apoptosis of human hepatocellular carcinoma SMMC-7721 cells through synergy of berberine and evodiamine,” Phytomedicine, vol. 15, no. 12, pp. 1062–1068, 2008. J. Yang, L.-J. Wu, S.-I. Tashino, S. Onodera, and T. Ikejima, “Critical roles of reactive oxygen species in mitochondrial permeability transition in mediating evodiamine-induced human melanoma A375-S2 cell apoptosis,” Free Radical Research, vol. 41, no. 10, pp. 1099–1108, 2007. Z.-G. Yang, A.-Q. Chen, and B. Liu, “Antiproliferation and apoptosis induced by evodiamine in human colorectal carcinoma cells (COLO-205),” Chemistry and Biodiversity, vol. 6, no. 6, pp. 924–933, 2009. I. Lavilla, M. Costas, P. S. Miguel, J. Millos, and C. Bendicho, “Elemental fingerprinting of tumorous and adjacent nontumorous tissues from patients with colorectal cancer using ICP-MS, ICP-OES and chemometric analysis,” BioMetals, vol. 22, no. 6, pp. 863–875, 2009. H. Sui, X. Liu, B. H. Jin et al., “Zuo Jin Wan, a traditional Chinese herbal formula, reverses P-gp-mediated MDR in vitro and in vivo,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 957078, 2013. D. M. Yong, C. Y. Min, H. L. Kyu, R. K. Kyung, U. C. Sang, and R. L. Kang, “Protoberberine alkaloids and their reversal activity of P-gp expressed multidrug resistance (MDR) from the rhizome of Coptis japonica makino,” Archives of Pharmacal Research, vol. 29, no. 9, pp. 757–761, 2006. C. He, R. Rong, J. Liu, J. Wan, K. Zhou, and J. X. Kang, “Effects of Coptis extract combined with chemotherapeutic agents on ROS production, multidrug resistance, and cell growth in A549 human lung cancer cells,” Chinese Medicine, vol. 7, no. 1, article 11, 2012. F.-R. Zhao, H.-P. Mao, H. Zhang et al., “Antagonistic effects of two herbs in Zuojin Wan, a traditional Chinese medicine formula, on catecholamine secretion in bovine adrenal medullary cells,” Phytomedicine, vol. 17, no. 8-9, pp. 659–668, 2010. K. Kolinsky, B.-Q. Shen, Y.-E. Zhang et al., “In vivo activity of novel capecitabine regimens alone and with bevacizumab and oxaliplatin in colorectal cancer xenograft models,” Molecular Cancer Therapeutics, vol. 8, no. 1, pp. 75–82, 2009. Y.-J. Mi, Y.-J. Liang, H.-B. Huang et al., “Apatinib (YN968D1) reverses multidrug resistance by inhibiting the efflux function of multiple ATP-binding cassette transporters,” Cancer Research, vol. 70, no. 20, pp. 7981–7991, 2010. C. Zhang, C. Wang, S. Tang et al., “TNFR1/TNF-a and mitochondria interrelated signaling pathway mediates quinocetoneinduced apoptosis in HepG2 cells,” Food and Chemical Toxicology, vol. 62, pp. 825–838, 2013.

10 ´ R. Nebreda, “Signal integration by JNK and [21] E. F. Wagner and A. p38 MAPK pathways in cancer development,” Nature Reviews Cancer, vol. 9, no. 8, pp. 537–549, 2009. [22] S. A. S. Sakinah, S. Tri Handayani, and L. P. A. Hawariah, “Zerumbone induced apoptosis in liver cancer cells via modulation of Bax/Bcl-2 ratio,” Cancer Cell International, vol. 7, article 4, 2007. [23] S. Cory, D. C. S. Huang, and J. M. Adams, “The Bcl-2 family: roles in cell survival and oncogenesis,” Oncogene, vol. 22, no. 53, pp. 8590–8607, 2003. [24] J. Xiang, D. T. Chao, and S. J. Korsmeyer, “BAX-induced cell death may not require interleukin 1𝛽-converting enzyme-like proteases,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 25, pp. 14559–14563, 1996. [25] Q. Mao, P. H. Zhang, Q. Wang, and S. L. Li, “Ginsenoside F2 induces apoptosis in humor gastric carcinoma cells through reactive oxygen species-mitochondria pathway and modulation of ASK-1/JNK signaling cascade in vitro and in vivo,” Phytomedicine, 2013. [26] M. C. Bi, R. Rosen, R. Y. Zha et al., “Zeaxanthin induces apoptosis in human uveal melanoma cells through Bcl-2 family proteins and intrinsic apoptosis pathway,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 205082, 12 pages, 2013. [27] M. Brentnall, L. Rodriguez-Menocal, R. L. De Guevara et al., “Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis,” BMC Cell Biology, vol. 14, article 32, 2013. [28] J. Shang, F. Yang, Y. Wang et al., “MicroRNA-23a antisense enhances 5-fluorouracil chemosensitivity through APAF-1/caspase-9 apoptotic pathway in colorectal cancer cells,” Journal of Cellular Biochemistry, vol. 115, no. 4, pp. 772–784, 2014.
